Phase
Condition
Ulcerative Colitis
Primary Biliary Cholangitis
Colic
Treatment
Gluten-free diet
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria (for PSC group):
Established diagnosis of PSC (based on radiologic features, typical finding on MRCP or ERCP)
Age 18 - 65 years
ALP 1,5x higher than ULN
Signed informed consent
Exclusion Criteria (for PSC group):
Patients on gluten-free diet
Patients with coeliac disease or wheat allergy
Liver transplant recipients
PSC/AIH overlap syndrome
Other causes of liver disease
Radiologic or clinical signs of decompensated liver cirrhosis
Advanced liver cirrhosis (MELD score ˃ 15)
Recurrent acute cholangitis or cholangiogenic sepsis in past 3 months
Use of antibiotics in past 3 months
History of malignancy
Pregnant women
Not signed informed consent
Inclusion criteria (for UC group):
Ulcerative colitis diagnosed based on clinical, endoscopic and histological findings
Extension of affected colon > 15cm
Mayo score 0-4
Signed informed consent
Exclusion criteria (for UC group):
CMV, Clostridium difficile enterocolitis in past 3 months
Use of antibiotics in past 3 months
Patients with coeliac disease or wheat allergy
Patients on gluten-free diet
Pregnant women
Not signed informed consent
Biologic therapy
Methotrexate
Prednison > 10 mg
Not signed informed consent
Study Design
Connect with a study center
Institute of clinical and experimental medicine
Prague 3067696, Prague 3067695 14021
CzechiaSite Not Available
Institute of clinical and experimental medicine
Prague, 14021
CzechiaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.